The Seropositivity Rate of Human Cytomegalovirus [Hcmv] Among Hepatitis B Virus [Hbv] Patients, Hepatitis C Virus [Hcv] Patients, and Blood Donors in Diyala Province

Abstract

The total number of samples was 112 that collected from 31 patients with hepatitis B virus [11 females and 20 males], 31 patients with hepatitis C virus [10 females and 21 males], and 50 males of blood donors during the period from the 1st of January, 2022, to the 1st of May, 2022. The samples were screened routinely for hepatitis C, hepatitis B virus, HIV, and Syphilis but not for HCMV. The goal of this research was to assess the incidence of HCMV IgG and HCMV IgM seropositivity in blood donors, HCV patients, and HBV patients in Diyala province using an enzyme-linked immunosorbent assay [ELISA]. The results revealed that the seropositivity of HCMV IgM was 3.2% in each of the HCV and HBV patients and 0.0% in blood donors. In contrast, the seropositivity of HCMV IgG was high among all study groups which were 96.8% among HCV patients, 100% among HBV patients, and 92% among blood donors. Based on the lifestyle, the percentage of HCMV IgM seropositivity for urban participants was 1.6%, and for rural participants, 2.0%. Meanwhile, the seropositivity of HCMV IgG was 96.7% in urban participants and 94.1% in rural participants.

Keywords

• CMV, HCV, HBV, Blood donors, CMV IgM, CMV IgG, Lifestyle